LeMaitre Vascular Inc. (LMAT)

LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.44 per share a year ago.

I've sold some higher-yielding stocks and reduced my portfolio yield in March. The goal was to get closer to my core strategy of investing only in companies with low dividend yields, but high dividend...

LeMaitre (LMAT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ro...

Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.

Over the past decade, the iShares S&P/TSX SmallCap Index ETF has underperformed broader markets due to its heavy exposure to resource-heavy sectors like energy and materials. Acme's dividend track rec...

Alimentation Couche-Tard has several growth vectors in place with a clear 5-year plan, including organic growth and growth by acquisition. Starting in March, I will increase my Smith Manoeuvre contrib...

LeMaitre (LMAT) could produce exceptional returns because of its solid growth attributes.

The Cheesecake Factory, LeMaitre Vascular and Huron Consulting Group are currently displaying superb earnings growth.

BlackRock is an interesting case study as I sold it for a nice profit even though the company's investment thesis is still intact. However, some metrics aren't as strong as before. I have a Telus posi...